M&A Deal Summary |
|
|---|---|
| Date | 2012-01-01 |
| Target | Roosevelt Kliniek |
| Sector | Healthcare Services |
| Buyer(s) | Plain Vanilla Investments |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| Size | Small |
| Type | Sector Agnostic |
Plain Vanilla Investments NV is a private independent investment and management firm specializing in divestment, growth capital and turn around transactions. The Firm targets to invest in companies where it can achieve substantial value increase by an active hands-on approach. Plain Vanilla invests in a wide range of industries, with special focus on healthcare. The sub-sectors in healthcare sector include Cure/Care: hospital care, nursing & home, elderly care, and specialist care; Medical equipment & devices: MRI, prosthesis; Services: diagnostic testing, facility management, real estate development and quality benchmarking. Plain Vanilla Investments NV is based in Amsterdam.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector: Healthcare Services M&A | 2 of 2 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 5 of 5 |
| Country: Netherlands M&A | 8 of 8 |
| Year: 2012 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-12-01 |
Steenland Chocolate BV
Gouda, Netherlands Steenland Chocolate commenced in 1899 as a family owned company. Today Steenland has become the world's leading company in the manufacture of chocolate coins and medallions with exports to over 70 countries. Customer service and product quality, combined with a high degree of flexibility, provide the best guarantee for creative but solid partnerships with its clients. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-03-03 |
DDL Diagnostic Laboratory BV
Rijswijk, Netherlands DDL Diagnostic Laboratory (DDL) is a testing and contract research laboratory specialized in molecular diagnostics. DDL performs advanced molecular diagnostic testing on behalf of pharmaceutical companies and clinical laboratories, often within the complex framework of Phase II-IV clinical trials. DDL was established in 1985 and is based in Rijswijk, Netherlands. |
Sell | - |
